Forum highlights research and FDA’s role in marketing herbal products

Dr. Suzette H. Lazo, Director IV of the Food and Drugs Administration (FDA) discusses the implication of ASEAN harmonization to herbal industry.

To identify gaps in the existing standards and regulations for the herbal industry,  the Philippine Council for Health Research and Development of the Department of Science and Technology (PCHRD-DOST) and AGHAM Party List sponsored a multi-sectoral meeting themed: “Philippine Herbal Industry-Standards and Regulatory Settings” last March 19, 2012 at the Traders Hotel, Pasay City.

Participants from various sectors – pharmaceutical industry sector, academic institutions, government and non-government organizations and media

Skip to content
Verified by MonsterInsights